Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroprotective strategies for inner retinal cone dysfunction in retinitis pigmentosa
2008-004561-26Phase 2Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Nerve growth factor and coenzyme q10 in retinitis pigmentosa (RP), sponsored by Policlinico Gemelli. Started Nov 2008; status: terminated.
02
Drugs
Nerve growth factorcoenzyme q10
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on 2008-004561-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004561-26.